Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2018

31.01.2018 | Original Article

Hypervigilance to a Gluten-Free Diet and Decreased Quality of Life in Teenagers and Adults with Celiac Disease

verfasst von: Randi L. Wolf, Benjamin Lebwohl, Anne R. Lee, Patricia Zybert, Norelle R. Reilly, Jennifer Cadenhead, Chelsea Amengual, Peter H. R. Green

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

Avoidance of gluten is critical for individuals with celiac disease (CD), but there is also concern that “extreme vigilance” to a strict gluten-free diet may increase symptoms such as anxiety and fatigue, and therefore, lower quality of life (QOL). We examined the associations of QOL with energy levels and adherence to, and knowledge about, a gluten-free diet.

Methods

This is a cross-sectional prospective study of 80 teenagers and adults, all with biopsy-confirmed CD, living in a major metropolitan area. QOL was assessed with CD-specific measures. Dietary vigilance was based on 24-h recalls and an interview. Knowledge was based on a food label quiz. Open-ended questions described facilitators and barriers to maintaining a gluten-free diet.

Results

The extremely vigilant adults in our sample had significantly lower QOL scores than their less vigilant counterparts [(mean (SD): 64.2 (16.0) vs 77.2 (12.2), p = 0.004]. Extreme vigilance was also associated with greater knowledge [5.7 (0.7) vs 5.1 (0.8), p = 0.035]. Adults with lower energy levels had significantly lower overall QOL scores than adults with higher energy levels [68.0 (13.6) vs 78.9 (13.0), p = 0.006]. Patterns were similar for teenagers. Cooking at home and using internet sites and apps were prevalent strategies used by the hypervigilant to maintain a strict gluten-free diet. Eating out was particularly problematic.

Conclusion

There are potential negative consequences of hypervigilance to a strict gluten-free diet. Clinicians must consider the importance of concurrently promoting both dietary adherence and social and emotional well-being for individuals with CD.
Literatur
1.
Zurück zum Zitat Green PHR, Krishnareddy S, Lebwohl B. Clinical manifestations of celiac disease. Dig Dis. 2015;33:137–140.CrossRefPubMed Green PHR, Krishnareddy S, Lebwohl B. Clinical manifestations of celiac disease. Dig Dis. 2015;33:137–140.CrossRefPubMed
2.
Zurück zum Zitat Abu Daya H, Lebwohl B, Lewis SK, et al. Celiac disease patients presenting with anemia have more severe disease than those presenting with diarrhea. Clin Gastroenterol Hepatol. 2013;11:1472–1477.CrossRefPubMed Abu Daya H, Lebwohl B, Lewis SK, et al. Celiac disease patients presenting with anemia have more severe disease than those presenting with diarrhea. Clin Gastroenterol Hepatol. 2013;11:1472–1477.CrossRefPubMed
3.
4.
Zurück zum Zitat Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538–1544.CrossRefPubMed Rubio-Tapia A, Ludvigsson JF, Brantner TL, et al. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107:1538–1544.CrossRefPubMed
5.
Zurück zum Zitat Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217–1225.CrossRefPubMed Lohi S, Mustalahti K, Kaukinen K, et al. Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther. 2007;26:1217–1225.CrossRefPubMed
6.
Zurück zum Zitat Rubio-Tapia A, Hill ID, Kelly CP, et al. American College of Gastroenterology. ACG guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676.CrossRefPubMedPubMedCentral Rubio-Tapia A, Hill ID, Kelly CP, et al. American College of Gastroenterology. ACG guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ludvigsson JF, Bai JC, Biagi F, et al. BSG Coeliac Disease Guidelines Development Group; British Society of Gastroenterology. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;64:1210–1228.CrossRef Ludvigsson JF, Bai JC, Biagi F, et al. BSG Coeliac Disease Guidelines Development Group; British Society of Gastroenterology. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;64:1210–1228.CrossRef
8.
Zurück zum Zitat Hornell A. Effects of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr. 2007;85:160–166.CrossRef Hornell A. Effects of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr. 2007;85:160–166.CrossRef
9.
Zurück zum Zitat Fabiani E, Catassi C. International Working Group. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow-up of coeliac disease: results of an international multi-center study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol. 2001;13:659–665.CrossRefPubMed Fabiani E, Catassi C. International Working Group. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow-up of coeliac disease: results of an international multi-center study. International Working Group on Eu-tTG. Eur J Gastroenterol Hepatol. 2001;13:659–665.CrossRefPubMed
10.
Zurück zum Zitat Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr. 2007;85:160–166.CrossRefPubMed Catassi C, Fabiani E, Iacono G, et al. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr. 2007;85:160–166.CrossRefPubMed
11.
Zurück zum Zitat Lebwohl B, Granath F, Ekbom A, et al. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med. 2013;159:169–175.CrossRefPubMedPubMedCentral Lebwohl B, Granath F, Ekbom A, et al. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med. 2013;159:169–175.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Meyer D, Stavropolous S, Diamond B, et al. Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol. 2001;96:112–119.PubMed Meyer D, Stavropolous S, Diamond B, et al. Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol. 2001;96:112–119.PubMed
13.
Zurück zum Zitat Lee AR, Diamond B, Ng D, et al. Quality of life of individuals with celiac disease: survey results from the United States. J Hum Nutr Diet. 2012;25:233–238.CrossRefPubMed Lee AR, Diamond B, Ng D, et al. Quality of life of individuals with celiac disease: survey results from the United States. J Hum Nutr Diet. 2012;25:233–238.CrossRefPubMed
14.
Zurück zum Zitat Ciacci C, D’Agate C, DeRosa A, et al. Self-rated quality of life in celiac disease. Dig Dis Sci. 2003;48:2216–2220.CrossRefPubMed Ciacci C, D’Agate C, DeRosa A, et al. Self-rated quality of life in celiac disease. Dig Dis Sci. 2003;48:2216–2220.CrossRefPubMed
15.
Zurück zum Zitat Zarkadas M, Dubois S, Maclsaac K, et al. Living with coeliac disease and a gluten-free diet: a Canadian perspective. J Hum Nutr Diet. 2013;26:10–23.CrossRefPubMed Zarkadas M, Dubois S, Maclsaac K, et al. Living with coeliac disease and a gluten-free diet: a Canadian perspective. J Hum Nutr Diet. 2013;26:10–23.CrossRefPubMed
16.
Zurück zum Zitat Shah S, Akbari M, Vanga R, et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109:1304–1311.CrossRefPubMedPubMedCentral Shah S, Akbari M, Vanga R, et al. Patient perception of treatment burden is high in celiac disease compared with other common conditions. Am J Gastroenterol. 2014;109:1304–1311.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Zignone F, Swift GL, Card TR, et al. Psychological morbidity of celiac disease: a review of the literature. United Eur Gastroenterol J. 2014;3:136–145. Zignone F, Swift GL, Card TR, et al. Psychological morbidity of celiac disease: a review of the literature. United Eur Gastroenterol J. 2014;3:136–145.
18.
Zurück zum Zitat Casellas F, Rodrigo L, Lucendo AJ, et al. Benefit of health-related quality of life of adherence to gluten-free diet in adult patients with celiac disease. Rev Esp Enferm Dig. 2015;107:196–201.PubMed Casellas F, Rodrigo L, Lucendo AJ, et al. Benefit of health-related quality of life of adherence to gluten-free diet in adult patients with celiac disease. Rev Esp Enferm Dig. 2015;107:196–201.PubMed
19.
Zurück zum Zitat Usai P, Minerba L, Marini B, et al. Case control study on health-related quality of life in adult coeliac disease. Dig Liver Dis. 2002;34:547–552.CrossRefPubMed Usai P, Minerba L, Marini B, et al. Case control study on health-related quality of life in adult coeliac disease. Dig Liver Dis. 2002;34:547–552.CrossRefPubMed
20.
Zurück zum Zitat Hauser W, Stallmach A, Caspary WF, et al. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther. 2007;25:569–578.CrossRefPubMed Hauser W, Stallmach A, Caspary WF, et al. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther. 2007;25:569–578.CrossRefPubMed
21.
Zurück zum Zitat Nachman F, Planzer del Campo M, Gonzalez A, et al. Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis. 2010;42:685–691.CrossRefPubMed Nachman F, Planzer del Campo M, Gonzalez A, et al. Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liver Dis. 2010;42:685–691.CrossRefPubMed
22.
Zurück zum Zitat White LE, Bannerman E, Gillett PM. Coeliac disease and the gluten free diet: a review of the burdens; factors associated with adherence and impact on health-related quality of life, with specific focus on adolescence. J Hum Nutr Diet. 2016;29:593–606.CrossRefPubMed White LE, Bannerman E, Gillett PM. Coeliac disease and the gluten free diet: a review of the burdens; factors associated with adherence and impact on health-related quality of life, with specific focus on adolescence. J Hum Nutr Diet. 2016;29:593–606.CrossRefPubMed
23.
Zurück zum Zitat Dorn SD, Hernandez L, Minayas MT, et al. The development and validation of a new coeliac disease quality of life survey (CD-QOL). Aliment Pharmacol Ther. 2009;31:666–675.CrossRefPubMed Dorn SD, Hernandez L, Minayas MT, et al. The development and validation of a new coeliac disease quality of life survey (CD-QOL). Aliment Pharmacol Ther. 2009;31:666–675.CrossRefPubMed
24.
Zurück zum Zitat Jordan NE, Li Y, Magrini D, et al. Development and validation of a celiac disease quality of life instrument for North American children. J Pediatr Gastroenterol Nutr. 2013;57:477–486.CrossRefPubMed Jordan NE, Li Y, Magrini D, et al. Development and validation of a celiac disease quality of life instrument for North American children. J Pediatr Gastroenterol Nutr. 2013;57:477–486.CrossRefPubMed
25.
Zurück zum Zitat Leffler DA, Dennis M, Edwards JB, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7:530–536.CrossRefPubMed Leffler DA, Dennis M, Edwards JB, et al. A simple validated gluten-free diet adherence survey for adults with celiac disease. Clin Gastroenterol Hepatol. 2009;7:530–536.CrossRefPubMed
26.
Zurück zum Zitat Braun V, Clarke V. What can “thematic analysis” offer health and wellbeing researchers? Int J Qual Stud Health Well-being. 2014;9:26152.CrossRefPubMed Braun V, Clarke V. What can “thematic analysis” offer health and wellbeing researchers? Int J Qual Stud Health Well-being. 2014;9:26152.CrossRefPubMed
27.
Zurück zum Zitat Barratt SM, Leeds JS, Sanders DS. Quality of life in coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointest Liver Dis. 2011;20:241–245. Barratt SM, Leeds JS, Sanders DS. Quality of life in coeliac disease is determined by perceived degree of difficulty adhering to a gluten-free diet, not the level of dietary adherence ultimately achieved. J Gastrointest Liver Dis. 2011;20:241–245.
28.
Zurück zum Zitat Hopman EGD, Koopman HM, Maarten Wit J, et al. Dietary compliance and health-related quality of life in patients with coeliac disease. Eur J Gastroenterol Hepatol. 2009;21:1056–1061.CrossRefPubMed Hopman EGD, Koopman HM, Maarten Wit J, et al. Dietary compliance and health-related quality of life in patients with coeliac disease. Eur J Gastroenterol Hepatol. 2009;21:1056–1061.CrossRefPubMed
32.
Zurück zum Zitat Addolorato G, DeLorenzi G, Abenavoli L, et al. Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders. Aliment Pharmacol Ther. 2004;20:777–782.CrossRefPubMed Addolorato G, DeLorenzi G, Abenavoli L, et al. Psychological support counselling improves gluten-free diet compliance in coeliac patients with affective disorders. Aliment Pharmacol Ther. 2004;20:777–782.CrossRefPubMed
33.
Zurück zum Zitat Meyer KG, Fasshauer M, Nebel IT, et al. Comparative analysis of conventional training and a computer-based interactive training program for celiac disease patients. Patient Educ Couns. 2014;54:353–360.CrossRef Meyer KG, Fasshauer M, Nebel IT, et al. Comparative analysis of conventional training and a computer-based interactive training program for celiac disease patients. Patient Educ Couns. 2014;54:353–360.CrossRef
34.
Zurück zum Zitat Ring Jacobsson L, Friedrichsen M, Al G, et al. Does a coeliac school increase psychological well-being in women suffering from coeliac disease, living on a gluten-free diet? J Clin Nurs. 2012;21:766–775.CrossRefPubMed Ring Jacobsson L, Friedrichsen M, Al G, et al. Does a coeliac school increase psychological well-being in women suffering from coeliac disease, living on a gluten-free diet? J Clin Nurs. 2012;21:766–775.CrossRefPubMed
35.
Zurück zum Zitat Sainbury K, Mullan B, Sharpe L. A randomized controlled trial of an online intervention to improve gluten-free diet adherence in celiac disease. Am J Gastroenterol. 2013;108:811–817.CrossRef Sainbury K, Mullan B, Sharpe L. A randomized controlled trial of an online intervention to improve gluten-free diet adherence in celiac disease. Am J Gastroenterol. 2013;108:811–817.CrossRef
Metadaten
Titel
Hypervigilance to a Gluten-Free Diet and Decreased Quality of Life in Teenagers and Adults with Celiac Disease
verfasst von
Randi L. Wolf
Benjamin Lebwohl
Anne R. Lee
Patricia Zybert
Norelle R. Reilly
Jennifer Cadenhead
Chelsea Amengual
Peter H. R. Green
Publikationsdatum
31.01.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-4936-4

Weitere Artikel der Ausgabe 6/2018

Digestive Diseases and Sciences 6/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.